Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | ARGX | RVMD | ||
| Company | Alnylam Pharmaceuticals | Argenx Se ADR | Revolution Medicines Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 299.51 | 832.86 | 159.95 | ||
| High | 303.98 | 840.29 | 165.80 | ||
| Low | 296.72 | 825.55 | 154.13 | ||
| Latest | 300.49 | 836.93 | 165.89 | ||
| Change | -1.49 | +0.94 | +8.41 | ||
| % Change | -0.49% | +0.11% | +5.34% | ||
| Volume | 567,810 | 161,736 | 4,683,121 | ||
| 20-Day Average Volume | 975,775 | 312,248 | 2,650,350 | ||
| Previous Close | 301.98 | 835.99 | 157.48 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 295.87 | 808.73 | 149.83 | ||
| 20-Day Raw Stochastic | 74.11% | 89.92% | 97.94% | ||
| 20-Day Relative Strength | 47.68 | 58.30 | 67.58 | ||
| Weighted Alpha | -13.44 | +36.34 | +152.31 | ||
| Today's Opinion | 88% Sell | 40% Buy | 100% Buy | ||
| Previous Opinion | 88% Sell | 40% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Sell | 8% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.99% since 05/22/26 | +3.79% since 05/22/26 | +8.08% since 05/22/26 | ||
| Low | 291.84 on 05/28/26 | 799.38 on 05/26/26 | 149.10 on 05/28/26 | ||
| High | 305.98 on 05/28/26 | 843.90 on 05/28/26 | 164.30 on 06/01/26 | ||
| 1-Month | |||||
| %Chg | +1.45% since 05/01/26 | +6.83% since 05/01/26 | +17.44% since 05/01/26 | ||
| Low | 284.28 on 05/11/26 | 775.62 on 05/19/26 | 140.53 on 05/08/26 | ||
| High | 306.03 on 05/06/26 | 843.90 on 05/28/26 | 164.30 on 06/01/26 | ||
| 3-Month | |||||
| %Chg | -9.77% since 02/27/26 | +9.14% since 02/27/26 | +60.57% since 02/27/26 | ||
| Low | 284.28 on 05/11/26 | 661.85 on 03/20/26 | 91.52 on 03/30/26 | ||
| High | 343.36 on 04/14/26 | 852.28 on 04/17/26 | 164.30 on 06/01/26 | ||
| 6-Month | |||||
| %Chg | -33.91% since 12/01/25 | -6.47% since 12/01/25 | +116.11% since 12/01/25 | ||
| Low | 284.28 on 05/11/26 | 661.85 on 03/20/26 | 73.00 on 12/16/25 | ||
| High | 479.79 on 12/03/25 | 934.62 on 12/03/25 | 164.30 on 06/01/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 40,318,256 | 51,988,536 | 33,479,616 | ||
| Shares Outstanding, K | 133,513 | 62,188 | 212,596 | ||
| Annual Sales | 3,713,940,000 | 4,248,050,000 | 0 | ||
| Annual Net Income | 313,750,000 | 1,292,040,000 | -1,131,300,000 | ||
| Last Quarter Sales | 1,167,180,000 | 1,313,000,000 | 0 | ||
| Last Quarter Net Income | 205,990,000 | 366,000,000 | -453,820,000 | ||
| 60-Month Beta | 0.31 | 0.46 | 1.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.99 on 04/30/26 | 5.52 on 05/07/26 | -2.29 on 05/06/26 | ||
| Earnings Date | 07/30/26 | 07/30/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 83.58 | 37.33 | 0.00 | ||